Skip to main content
logo
Rekvina Laboratories Limited (BOM:526075)
India flag India · Delayed Price · Currency is INR
54.90
+1.07 (1.99%)
At close: Sep 7, 2026

Rekvina Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
19.3412.65----
Revenue Growth
------
Gross Profit
0.960.84----
Operating Income
-3.4-2.55-1.37-0.16-0.04-0.75
Net Income
-3.4-2.55-1.37-0.16-0.01-0.79
Earnings Per Share
-0.56-0.42-0.23-0.03-0.00-0.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.150.150.250.10.10
Total Debt
14.7314.732.470.40.81-
Net Cash (Debt)
-14.57-14.57-2.22-0.3-0.720
Net Cash Growth
------82.48%
Net Cash Per Share
-2.39-2.40-0.37-0.05-0.120.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--5.94-1.92-0.080.1-0.4
Free Cash Flow
--5.94-1.92-0.080.1-0.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
4.98%6.62%----
Operating Margin
-17.57%-20.13%----
Pretax Margin
-17.57%-20.13%----
Profit Margin
-17.57%-20.13%----

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
16.7817.22----